BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This specialized biomimetic model formulation features a ternary lipid bilayer matrix engineered to closely mimic bacterial inner membrane layouts. The structural framework self-assembles from a precise, micro-calibrated molecular blend of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), 1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DPPG), and natural cardiolipin (CL) without containing active drug cargo. This combination introduces an optimized amphiphilic landscape characterized by negative surface charge density and localized negative membrane curvature, providing an exceptional cell-free reference standard for tracking membrane elasticity, lateral lipid domain separation, and antimicrobial peptide interaction thermodynamics.
Source
Custom synthesis
Functional Group
POPE; DPPG; Cardiolipin (CL)
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.